Lastly, the single-dose administration (20 mg/kg) of two novel anti-c-KIT antibody–drug conjugates, with novel NAMPT inhibitors as payloads, efficiently blocked in vivo tumor proliferation in c-Kit-positive gastrointestinal stromal tumor GIST-T1 mouse xenografts [117]. Here, NAMPT is linked to neoplasm.